Влияние гипергликемии и гиперинсулинемии на уровень мочевой кислоты и течение артрита у больных подагрой с сахарным диабетом 2 типа

Полный текст:

Список литературы

1. Барскова В.Г., Елисеев М.С., Насонов Е.Л. с соавт. Синдром инсулинорезистентности у больных подагрой и его влияние на формирование клинических особенностей болезни. Тер архив 2004; 5:51-55.

2. Насонова В.А., Барскова В.Г. Ранние диагностика и лечение подагры - научно обоснованное требование улучшения трудового и жизненного прогноза больных. Научно-практическая ревматология 2004, 1, 5-7.

3. Alberty K.G., Zimmet P.Z. For the WHO Consultation Group. Defiinition, diagnosis and classification of diabetes mellitus and its complication. Part I:Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 539-553.

4. Alcazar J., Ruilope L., Ladron de Guevara P. Hiperuricemia e hipertension arterial esencial. Nefrologia 1982; 2:145-149.

5. Berkowitz D. Gout, hyperlipidemia and diabetes interrelationships. JAMA 1966; 197:77-80.

6. Bo S., Cavallo-Perin P., Gentile L., et al. Hypouricaemia and hyperuricaemia in type 2 diabetes:two different phenotypes. Eur J Clin Invest 2001. 31(4):318-321.

7. Borona E., Targer G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assesment of insulin sensitivity. Diabetes Care 2000; 23:57-63.

8. Canon P.J., Simson W.B., Demartini F.E. Hyperuricemia in primary and renal hypertension. N Engl J Med 1966; 275:457-464.

9. Chou P., Lin K.C., Lin H.Y. and Tsai S.T. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheum. 2001; 28:3, 571-576.

10. Cook D.G., Shaper A.G., Thelle D.S., Whitehead T.P. Serum uric acid, serum glucose and diabetes:relations in a population study. Postgrad Med J 1986; 262:1001-6.

11. Denis G., Launay M.P. Carbohydrate intolerance in gout. Metabolism 1969; 18:770-775.

12. Dessein P.H., Stanwix A.E., Shipton E.A., Joffe B.I., van der Merwe C.A. Dislipidemia and insulin resistance in gout:sufficiently common to be considered in the evaluation and management of every patient. III. African League Against Rheumatism (AFLAR) Conference. Cape Town, South Africa, September 1999. Cape Town:Ukenza, 199.9.

13. Еngelhardt H.T., Wagner E.L. Gout, diabetes mellitus and obesity, a poorly recognized syndrome. South Med J 1950; 43:51-53.

14. Facchini F., Ida Chen Y.D., Hollenbeck C.B., Reaven G.M. Relationship between resistance to insulin mediated glucose uptake, urinary acid clearance and plasma uric acid concentration. JAMA 1991; 266:3008-3011.

15. Haffner S.M., Gonzalez C., Miettinen H. et al. A prospective analysis of the HOMA model:the Mexico City Diabetes Study. Diabetes Care 1996; 19:1138-1141.

16. Herman J.B., Mount F.W., Medalie J.H., et al. Diabetes prevalence and serum uric acid:Observations among 10,000 men in a survey of ischemic heart disease in Israel. Diabetes 1967; 16:858-868.

17. Herman J.B., Goldbourt U. Uric acid and diabetes:observation in population study. Lancet 1982.

18. Lin K., Tsao H., Chen C., Chou P. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia. J Rheum 2004; 31:66, 1152-1158.

19. Masanori E., Yoshiki N., Kiyoshi M., Yoshikazu H. et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22:818-822.

20. Mikkelsen W.M. The possible association of hyperuricemia and/or gout with diabetes mellitus. Arthritis Rheum 1965; 8:853-864.

21. Muscelli E., Natali A., Bianchi S. et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996; 9:746-752.

22. Myers A., Epstein F.H., Dodge H.J. The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med 1968; 45:520-528.

23. Padova J., Patchefsky A., Onesti G., et al. The effect of glucose loads on renal uric acid excretion in diabetic patients. Metabolism 1964. 13:507-512.

24. Puig J.G., Ruilope L.M. Uric acid as a cardiovascular risk factors in arterial hypertension. J Hypertens 1999; 17:869-872.

25. Reaven G.M. Role of insulin resistance in human disease:Banting lecture. Diabetes 1988; 37:1595-1607.

26. Ruilope L., Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertension Rep 2001; 3:197-202.

27. Takahashi S., Moriwaki Y., Tsutsumi Z. et al. Increased visceral fat accomulation further aggravates the risk of insulin resistance in gout. Metabolism 2001 Apr. 50(4):393-8.

28. Ter Maaten J.C., Voorburg A., Heine R.J. et al. Renal handling during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci Lond 1997; 92:51-58.

29. Tuomilehto J., Zimmet P., Wolf E., et al. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in biracial population of Fiji. Am J Epidemiol 1988; 127:321-326.

30. Wallace S.L., Robinson H., Masi A.T., et al. Preliminary criteria for the classification of the acute arthritis of gout. Arthritis Rheum 1977; 20:895-900.

31. Whitehead T.P., Jungner I., Robinson D., et al. Serum urate, serum glucose and diabetes. Ann Clin Biochem 1992; 29:159-161.

Для цитирования:

Barskova V.G., Eliseev M.S., Zilov A.V., Nasonov E.L. Влияние гипергликемии и гиперинсулинемии на уровень мочевой кислоты и течение артрита у больных подагрой с сахарным диабетом 2 типа. Ожирение и метаболизм. 2007;4(1):19-23.

For citation:

., ., ., . Vliyanie giperglikemii i giperinsulinemii na uroven' mochevoy kisloty i techenie artrita u bol'nykh podagroy s sakharnym diabetom 2 tipa. Obesity and metabolism. 2007;4(1):19-23. (In Russ.)

Просмотров: 10

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)